Farrell Michael J.'s Form 4 filing
Resmed Inc (RMD) · filed May 9, 2025
- Accession no.
- 0001127602-25-013796
- Filed
- May 9, 2025
- Trade date
- May 7, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.95M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Farrell Michael J.CIK 0001485164 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2025 | ResMed Common Stock | MOption exerciseAcquired | +8,009 | $101.64 | +$814,034.76 | 463,512 | Direct | |
| May 7, 2025 | ResMed Common Stock | SSaleDisposed | −8,009 | $243.23 | −$1,948,029.07 | 455,503 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2025 | ResMed Common Stock | MOption exerciseDisposed | −8,009 | $0.00 | $0 | 48,056 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.